Fig. 8From: A novel TCGA-validated programmed cell-death-related signature of ovarian cancer(A) Pathways enriched via GO and KEGG analysis in the high-risk group(B) TME score in different risk score groups. (C,D) Immune molecular expression. (E) Immune checkpoints. (*P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant)Back to article page